Kaylan Brodnax v. HHS - Influenza, transverse myelitis (2018)
Case summary [AI summaries can sometimes make mistakes]
Kaylan Brodnax filed a petition on August 9, 2018, seeking compensation under the National Vaccine Injury Compensation Program. Petitioner alleged that she suffered from transverse myelitis (TM) as a result of an influenza vaccine received on October 7, 2014, and that she experienced residual effects from the condition for more than six months.
The respondent denied that the flu vaccine caused Petitioner's TM or any other injury. However, both parties agreed to settle the case through a stipulation filed on August 6, 2018.
Special Master Brian H. Corcoran reviewed the stipulation and found it reasonable, adopting it as the decision.
The stipulation awarded Kaylan Brodnax a lump sum of $55,000.00 as compensation for all damages. The decision was issued on September 19, 2018.
Petitioner's counsel was David Joseph Schexnaydre. Respondent's counsel was Robert Paul Coleman, III.
Theory of causation
Petitioner alleged that she suffered from transverse myelitis (TM) as a result of her October 7, 2014, influenza ("flu") vaccine and experienced residual effects for more than six months. Respondent denied causation. The parties settled the case via stipulation, which was adopted by Special Master Brian H. Corcoran. The stipulation awarded Petitioner $55,000.00 for all damages. The public decision does not describe the specific mechanism of injury, onset of symptoms, medical tests, treatments, or expert witnesses. The decision was issued on September 19, 2018. Petitioner's counsel was David Joseph Schexnaydre, and Respondent's counsel was Robert Paul Coleman, III.
Source PDFs
USCOURTS-cofc-1_16-vv-01706